European Urology - Magnetic Resonance Urethrography in Comparison to Retrograde Urethrography in Diagnosis of Male Urethral Strictures: Is It Clinically Relevant?
Wednesday, 06 September 2006
Volume 50, Issue 3, Pages 587-594 (September 2006) 1. Introduction: The male urethra is a tubular structure approximately 18–20cm long and runs from the bladder to the external urethral meatus.
read more
|
European Urology - Psychobiologic Correlates of the Metabolic Syndrome and Associated Sexual Dysfunction
Wednesday, 06 September 2006
Volume 50, Issue 3, Pages 595-604 (September 2006) 1. Introduction: A worldwide epidemic increase in obesity has occurred in recent decades and will steadily increase in the near future, due to substantial lifestyle changes [1].
read more
|
European Urology - The Association Between Vascular Risk Factors and Lower Urinary Tract Symptoms in Both Sexes
Tuesday, 05 September 2006
, Issue 3, Pages 581-586 (September 2006)
Abstract -
Objectives:
To test the potential role of atherosclerosis in the development of lower urinary tract symptoms (LUTS), we investigated the association between vascular risk factors and LUTS in both sexes.
read more
|
European Urology - A Randomised Trial Comparing Holmium Laser Enucleation Versus Transurethral Resection in the Treatment of Prostates Larger Than 40Grams: Results at 2 Year
Tuesday, 05 September 2006
Volume 50, Issue 3, Pages 569-573 (September 2006) 1. Introduction The surgical management of men with large prostates (>40g) that cause bladder outflow obstruction (BOO) secondary to benign prostatic hyperplasia (BPH) is a challenging area.
read more
|
European Urology - A New Artificial Urinary Sphincter with Conditional Occlusion for Stress Urinary Incontinence: Preliminary Clinical Results
Tuesday, 05 September 2006
Volume 50, Issue 3, Pages 574-580 (September 2006) 1. Introduction: Hydraulically controlled artificial urinary sphincters (AUSs) have been used in the treatment of stress incontinence for nearly 30 years.
read more
|
European Urology - Holmium Laser Enucleation of the Prostate Versus Open Prostatectomy for Prostates >70g: 24-Month Follow-up
Thursday, 31 August 2006
Volume 50, Issue 3, Pages 563-568 (September 2006) 1. Introduction: Open prostatectomy (OP) is the most common surgical approach for benign prostate hyperplasia (BPH) in large prostates in many parts of Europe [1], [2].
read more
|
European Urology - Characteristics of Patients Presenting with LUTS/BPH in Six European Countries
Friday, 01 September 2006
Volume 50, Issue 3, Pages 555-562 (September 2006) Abstract - Objectives: Knowledge of the clinical profile of the population with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) is important for health care management, impacting on manpower requirements, pharmacologic demands and health service costs.
read more
|
European Urology - Intake of Selected Micronutrients and the Risk of Surgically Treated Benign Prostatic Hyperplasia: A Case-Control Study from Italy
Friday, 01 September 2006
Volume 50, Issue 3, Pages 549-554 (September 2006) 1. Introduction: Although benign prostatic hyperplasia (BPH) is a very common disease in older men [1], [2], little is known about its etiology [3], [4], except for an involvement of androgens in its development and maintenance [5], [6], [7].
read more
|
European Urology - Early Experience of a Living Donor Kidney Transplant Program
Friday, 01 September 2006
Volume 50, Issue 3, Pages 542-548 (September 2006) Abstract - Objectives: Laparoscopic nephrectomy has been shown to reduce the morbidity of live donor nephrectomy, but post-transplant kidney function and safety issues with the procedure are still of some concern.
read more
|
European Urology - Ureteral Complications in the Renal Transplant Recipient after Laparoscopic Living Donor Nephrectomy
Friday, 01 September 2006
Volume 50, Issue 3, Pages 535-541 (September 2006) Abstract - Objectives: We report on ureteral and surgical complications in our first 110 consecutive recipients of kidneys procured with laparoscopic living donor nephrectomy (LLDN).
read more
|
European Urology - Association of Mast Cells with Microvessel Density in Renal Cell Carcinomas
Friday, 01 September 2006
Volume 50, Issue 3, Pages 530-534 (September 2006)
Abstract -
Background:
Growth of solid tumors requires angiogenesis. Evidence indicates that mast cells (MCs) play an important role in tumor angiogenesis.
read more
|
European Urology - Tumor Size Improves the Accuracy of TNM Predictions in Patients with Renal Cancer
Friday, 01 September 2006
Volume 50, Issue 3, Pages 521-529 (September 2006) Abstract - Objectives: Current staging for renal cancer (RC) does not directly rely on tumor size. We examined the increment in accuracy related to inclusion of pathologically determined tumor size in prediction of nodal metastases (N+), distant metastases (M+), and cancer-specific survival (CSS).
read more
|
European Urology - Should Bladder Biopsies be Performed Routinely after Bacillus Calmette-Guérin Treatment for High-Risk Superficial Transitional Cell Cancer of the Bladder?
Friday, 01 September 2006
Volume 50, Issue 3, Pages 516-520 (September 2006) Abstract -
Objective:
After endoscopic resection of high-grade superficial urothelial neoplasms (Ta, T1 or Tis), adjuvant bacillus Calmette-Guérin (BCG) therapy is performed routinely to avoid recurrence and/or progression. Vesical biopsies often are performed to assess the efficacy of treatment. The aim of our study was to evaluate the usefulness of these biopsies.
read more
|
European Urology - Molecular and Immunohistochemical Analysis of the Prognostic Value of Cell-Cycle Regulators in Urothelial Neoplasms of the Bladder
Tuesday, 29 August 2006
Volume 50, Issue 3, Pages 506-515 (September 2006)
Abstract -
Objective:
To evaluate the prognostic and predictive value of molecular and immunohistochemical markers related to cell-cycle control in terms of recurrence, progression, and survival in urothelial neoplasms of the bladder (UNB).
read more
|
European Urology - High Incidence of Prostate Cancer Detected by Saturation Biopsy after Previous Negative Biopsy Series
Tuesday, 29 August 2006
Volume 50, Issue 3, Pages 498-505 (September 2006)
Abstract -
Objectives:
We explored the yield of saturation biopsy and developed a nomogram predicting the probability of prostate cancer (PCa) on the basis of saturation biopsy.
read more
|
European Urology - Evaluation of Color Doppler in Guiding Prostate Biopsy after HIFU Ablation
Tuesday, 29 August 2006
Volume 50, Issue 3, Pages 490-497 (September 2006)
Abstract -
Objective:
Transrectal ultrasound cannot accurately depict early cancer recurrences after prostate high-intensity focused ultrasound (HIFU) ablation. We evaluated transrectal color Doppler (CD) in guiding post-HIFU prostate biopsy.
read more
|
European Urology - Bulbar Urethroplasty with Dorsal Onlay Buccal Mucosal Graft and Fibrin Glue
Tuesday, 29 August 2006
Volume 50, Issue 3, Pages 467-474 (September 2006)
Abstract -
Objectives:
We describe a new surgical technique with the use of fibrin glue for bulbar urethra reconstruction using a dorsal buccal mucosal onlay graft.
read more
|
European Urology - Duration of Testosterone Suppression after a 9.45mg Implant of the GnRH-Analogue Buserelin in Patients with Localised Carcinoma of the Prostate: A 12-Month Follow-up Study
Tuesday, 29 August 2006
Volume 50, Issue 3, Pages 483-489 (September 2006)
Abstract -
Objectives:
(1) To determine the duration of androgen deprivation after a single buserelin implant 9.45mg in the neoadjuvant setting in combination with curative radiation therapy of carcinoma of the prostate, and (2) to evaluate the time to recovery of gonadal function, and the incidence and duration of hypogonadal symptoms.
read more
|
European Urology - Management and Survival of Screen-Detected Prostate Cancer Patients who Might Have Been Suitable for Active Surveillance
Tuesday, 29 August 2006
Volume 50, Issue 3, Pages 475-482 (September 2006) 1. Introduction Screening has caused a marked increase in prostate cancer incidence, although whether the stage and grade shift that has been caused by prostate-specific antigen (PSA)-based screening reduces the prostate cancer mortality is unclear.
read more
|
European Urology - Serotonin and Premature Ejaculation: From Physiology to Patient Management
Tuesday, 29 August 2006
Volume 50, Issue 3, Pages 454-466 (September 2006)
Abstract -
Introduction:
Premature ejaculation (PE), whose pathophysiology is still not clearly identified, is the most common male sexual dysfunction, yet it remains underdiagnosed and undertreated. The aims of this paper are to provide a scientific and pharmacologic rationale, and to discuss to what extent selective serotonin reuptake inhibitors (SSRIs) can help patients with PE.
read more
|
European Urology - The Placebo Effect in the Pharmacologic Treatment of Patients with Lower Urinary Tract Symptoms
Tuesday, 29 August 2006
Volume 50, Issue 3, Pages 440-453 (September 2006)
Abstract -
Objectives:
We reviewed placebo responses in randomised controlled trials (RCTs) for pharmacologic treatment of lower urinary tract symptoms (LUTS), including urinary incontinence (UI), overactive bladder, and benign prostatic hyperplasia. Review papers on placebo effects in non-urologic disorders were assessed to compare the magnitude of placebo responses in drugs for LUTS with those reported for other diseases.
read more
|
European Urology - Management of the Spectrum of Hormone Refractory Prostate Cancer
Tuesday, 29 August 2006
Volume 50, Issue 3, Pages 428-439 (September 2006)
Abstract -
Introduction:
In its advanced stages, hormone refractory prostate cancer (HRPC) is an incurable condition which consists of a spectrum of disease. This requires an integrated multidisciplinary approach by an uro-oncologic team supported by radiologists, skeletal surgeons and palliative care. Aim of this review was to critically evaluate the current and potential approaches to patients affected by HRPC.
read more
|
